At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 target
Drug / intervention
Video Capsule Endoscopyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
In Brief
A clinical study evaluating Video Capsule Endoscopy for Acute Coronary Syndrome. Completed, enrolled 30 participants across 1 site.
Detailed Summary
To determine the rate of symptomatic and asymptomatic gastrointestinal erosions and ulcerations in patients on dual antiplatelet (aspirin and clopidogrel) therapy after percutaneous coronary intervention (PCI).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Coronary Syndrome
CountriesUnited States
CollaboratorsAstraZeneca
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2006
First PostedDec 2006
Primary CompletionDec 2007
Study CompletionDec 2008
TodayJul 2026
First PostedDec 19, 2006
Enrollment StartApr 1, 2006
Primary CompletionDec 1, 2007
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 19.5 years ago
Interventions
Video Capsule Endoscopyprocedure
Noninvasive pill endoscopy is undertaken after 90 days of Aspirin/Clopidogrel in patients who have had percutaneous coronary intervention with drug-eluting stents.